Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001293971-24-000049
Filing Date
2024-09-26
Accepted
2024-09-26 16:01:43
Documents
21
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A blue-20240926.htm   iXBRL DEF 14A 1040470
6 blue-20240926_g1.jpg GRAPHIC 143071
7 blue-20240926_g2.jpg GRAPHIC 11600
8 blue-20240926_g3.jpg GRAPHIC 7404
9 blue-20240926_g4.jpg GRAPHIC 94473
10 blue-20240926_g5.jpg GRAPHIC 108275
11 blue-20240926_g6.jpg GRAPHIC 4783530
12 blue-20240926_g7.jpg GRAPHIC 4309807
  Complete submission text file 0001293971-24-000049.txt   21305256

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240926.xsd EX-101.SCH 2471
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blue-20240926_def.xml EX-101.DEF 2654
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240926_lab.xml EX-101.LAB 2960
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240926_pre.xml EX-101.PRE 1725
23 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240926_htm.xml XML 85634
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35966 | Film No.: 241328792
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)